OA17543A - Pharmaceutical composition for treating headache, and preparation method thereof. - Google Patents
Pharmaceutical composition for treating headache, and preparation method thereof. Download PDFInfo
- Publication number
- OA17543A OA17543A OA1201500253 OA17543A OA 17543 A OA17543 A OA 17543A OA 1201500253 OA1201500253 OA 1201500253 OA 17543 A OA17543 A OA 17543A
- Authority
- OA
- OAPI
- Prior art keywords
- éthanol
- extract
- filtered
- préparation
- give
- Prior art date
Links
- 206010019233 Headache Diseases 0.000 title claims abstract description 25
- 231100000869 headache Toxicity 0.000 title claims abstract description 25
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 35
- 208000002173 Dizziness Diseases 0.000 claims abstract description 5
- 210000003792 Cranial Nerves Anatomy 0.000 claims abstract description 4
- 206010022437 Insomnia Diseases 0.000 claims abstract description 4
- 206010052769 Vertigos Diseases 0.000 claims abstract description 4
- 201000010874 syndrome Diseases 0.000 claims abstract description 4
- 230000000472 traumatic Effects 0.000 claims abstract description 4
- 231100000889 vertigo Toxicity 0.000 claims abstract description 4
- 206010022998 Irritability Diseases 0.000 claims abstract description 3
- 239000000284 extract Substances 0.000 claims description 170
- 239000002002 slurry Substances 0.000 claims description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 56
- 210000000582 Semen Anatomy 0.000 claims description 42
- 238000010992 reflux Methods 0.000 claims description 42
- 241000217407 Margaritifera Species 0.000 claims description 41
- 238000010438 heat treatment Methods 0.000 claims description 39
- 241001199012 Usta Species 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 36
- 229920001353 Dextrin Polymers 0.000 claims description 20
- 239000004375 Dextrin Substances 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 20
- 235000019425 dextrin Nutrition 0.000 claims description 20
- 238000011049 filling Methods 0.000 claims description 19
- 239000012535 impurity Substances 0.000 claims description 19
- 239000007921 spray Substances 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 18
- 239000008213 purified water Substances 0.000 claims description 16
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 13
- 239000000796 flavoring agent Substances 0.000 claims description 12
- 235000013355 food flavoring agent Nutrition 0.000 claims description 12
- 238000005469 granulation Methods 0.000 claims description 10
- 230000003179 granulation Effects 0.000 claims description 10
- 239000012467 final product Substances 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- IAOZJIPTCAWIRG-QWRGUYRKSA-N Aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 6
- 229960003438 Aspartame Drugs 0.000 claims description 6
- 108010011485 Aspartame Proteins 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims description 6
- 239000000605 aspartame Substances 0.000 claims description 6
- 235000010357 aspartame Nutrition 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 claims description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 238000007792 addition Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- GUBGYTABKSRVRQ-ASMJPISFSA-N α-maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-ASMJPISFSA-N 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 39
- 229940079593 drugs Drugs 0.000 abstract description 26
- 241000218176 Corydalis Species 0.000 abstract description 4
- 241000758794 Asarum Species 0.000 abstract description 2
- 230000000240 adjuvant Effects 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000201986 Cassia tora Species 0.000 abstract 1
- 235000014552 Cassia tora Nutrition 0.000 abstract 1
- 240000001371 Chamaedaphne calyculata Species 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 241000521581 Millettia Species 0.000 abstract 1
- 240000001816 Prunella vulgaris Species 0.000 abstract 1
- 235000010674 Prunella vulgaris Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000607122 Uncaria tomentosa Species 0.000 abstract 1
- 235000011756 Vitis shuttleworthii Nutrition 0.000 abstract 1
- 235000011472 cat’s claw Nutrition 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 235000013685 leatherleaf Nutrition 0.000 abstract 1
- 235000013687 leatherleaf Nutrition 0.000 abstract 1
- 235000013691 leatherleaf Nutrition 0.000 abstract 1
- 239000008187 granular material Substances 0.000 description 31
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 22
- 238000000034 method Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 241000700159 Rattus Species 0.000 description 16
- 239000007788 liquid Substances 0.000 description 14
- 210000004369 Blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 13
- 230000002393 scratching Effects 0.000 description 13
- 238000006748 scratching Methods 0.000 description 13
- 239000002131 composite material Substances 0.000 description 12
- 239000012530 fluid Substances 0.000 description 12
- 239000004033 plastic Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 10
- BKQVCDGQNOKQNF-KFFVICKMSA-N Corynoxine B Natural products O=C(OC)/C(=C\OC)/[C@@H]1[C@H](CC)C[N+]2[C@H]([C@@]3(C(=O)Nc4c3cccc4)CC2)C1 BKQVCDGQNOKQNF-KFFVICKMSA-N 0.000 description 9
- DAXYUDFNWXHGBE-KAXDATADSA-N Rhynchophylline Chemical compound O=C1NC2=CC=CC=C2[C@@]11CCN2C[C@H](CC)[C@@H](\C(=C/OC)C(=O)OC)C[C@H]21 DAXYUDFNWXHGBE-KAXDATADSA-N 0.000 description 9
- JLUFWMXJHAVVNN-UHFFFAOYSA-N Methyltrichlorosilane Chemical compound C[Si](Cl)(Cl)Cl JLUFWMXJHAVVNN-UHFFFAOYSA-N 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 206010027599 Migraine Diseases 0.000 description 7
- 208000008085 Migraine Disorders Diseases 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- DUUGKQCEGZLZNO-UHFFFAOYSA-N 5-hydroxyindoleacetic acid Chemical compound C1=C(O)C=C2C(CC(=O)O)=CNC2=C1 DUUGKQCEGZLZNO-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000009114 investigational therapy Methods 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- SNIOPGDIGTZGOP-UHFFFAOYSA-N 1,2,3-propanetrioltrinitrate Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 5
- 229940014995 Nitroglycerin Drugs 0.000 description 5
- 239000000006 Nitroglycerin Substances 0.000 description 5
- 230000000975 bioactive Effects 0.000 description 5
- 229960003711 glyceryl trinitrate Drugs 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 4
- 210000004556 Brain Anatomy 0.000 description 3
- 210000004185 Liver Anatomy 0.000 description 3
- 230000002730 additional Effects 0.000 description 3
- 229930013930 alkaloids Natural products 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- 229960000583 Acetic Acid Drugs 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N Chrysophanic acid Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- VRSRXLJTYQVOHC-YEJXKQKISA-N Corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 2
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 2
- 241000668709 Dipterocarpus costatus Species 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N Emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N Ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010061255 Ischaemia Diseases 0.000 description 2
- DAXYUDFNWXHGBE-VKCGGMIFSA-N Isorhynchophylline Chemical compound O=C1NC2=CC=CC=C2[C@]11CCN2C[C@H](CC)[C@@H](\C(=C/OC)C(=O)OC)C[C@H]21 DAXYUDFNWXHGBE-VKCGGMIFSA-N 0.000 description 2
- DAXYUDFNWXHGBE-HLKYYGKDSA-N Isorhynchophylline Natural products O=C1NC2=CC=CC=C2[C@]11CCN2C[C@H](CC)[C@@H](\C(=C\OC)C(=O)OC)C[C@H]21 DAXYUDFNWXHGBE-HLKYYGKDSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 210000004165 Myocardium Anatomy 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N Parietin Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 230000003213 activating Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000002429 anti-coagulation Effects 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 230000003542 behavioural Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- -1 but not limited to Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 230000000916 dilatatory Effects 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 229930005303 indole alkaloids Natural products 0.000 description 2
- 150000002475 indoles Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 201000008125 pain agnosia Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 240000001992 Angelica archangelica Species 0.000 description 1
- 229940030609 CALCIUM CHANNEL BLOCKERS Drugs 0.000 description 1
- 229960002327 Chloral Hydrate Drugs 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N Chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M Coomassie Brilliant Blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 210000004351 Coronary Vessels Anatomy 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- HKIDROLXYXYQOZ-UHFFFAOYSA-N Dehydrocorydaline Chemical compound C1C2=C(OC)C(OC)=CC=C2C(C)=C2N1CCC1=C2C=C(OC)C(OC)=C1 HKIDROLXYXYQOZ-UHFFFAOYSA-N 0.000 description 1
- RFKQJTRWODZPHF-UHFFFAOYSA-N Dehydrocorydaline Natural products COC1=C(OC)C=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C(C)=C3C2=C1 RFKQJTRWODZPHF-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N Diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229940023488 Pill Drugs 0.000 description 1
- 208000008425 Protein Deficiency Diseases 0.000 description 1
- 210000003324 RBC Anatomy 0.000 description 1
- 229940085605 Saccharin Sodium Drugs 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- 229960001462 Sodium Cyclamate Drugs 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Sodium cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FINHMKGKINIASC-UHFFFAOYSA-N TMPZ Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-KRWDZBQOSA-N Tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 1
- AEQDJSLRWYMAQI-QGZVFWFLSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-QGZVFWFLSA-N 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 Xylitol Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 230000001914 calming Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 125000003346 cobalamin group Chemical group 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229930016859 corydaline Natural products 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000534 elicitor Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N flavone Chemical compound O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 229930003944 flavones Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000021285 flavonoid Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229930003935 flavonoids Natural products 0.000 description 1
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 1
- 235000008191 folinic acid Nutrition 0.000 description 1
- 239000011672 folinic acid Substances 0.000 description 1
- 210000004744 fore-foot Anatomy 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000010247 gou-teng Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229960001691 leucovorin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000000414 obstructive Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000001624 sedative Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002889 sympathetic Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Abstract
A pharmaceutical composition for treating headache, prepared from eleven Chinese herbal medicines: Chinese angelica root, ligusticum chuanxiong, radix paeoniae lactiflorae, prepared rhizome of rehmannia, uncaria tomentosa, leatherleaf milletia, prunella vulgaris, sicklesenna seed, pearl shell, corydalis tuber, and asarum, and a proper amount of adjuvant materials. A preparation method of the pharmaceutical composition, and uses thereof in the preparation of drugs for treating various headaches, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.
Description
PHARMACEUTICAL COMPOSITION FOR TREATING HEADACHE, AND PREPARATION METHOD THEREOF
FIELD OF THE INVENTION
The présent invention relates to the field of Traditional Chinese medicine (TCM). More specifically, the invention relates to pharmaceutical composition for treating headache, préparative method and its use thereof.
BACKGROUD OF THE INVENTION io Headache is a common symptom in daily life. Almost everyone will hâve headache in lifetime. The causes of headache are varied. By now, there are a lot of drugs for treating headache abroad or in China, most of which, however, focus on symptomatic treatment of stopping ache (in very few cases, headache is treated by surgery). The results are not satisfactory, because the drugs focus on symptomatic treatment rather than root cause. As a resuit of this, headache attacks patients recurrently. Long-term use of analgésie agents may cause drug résistance and addiction, so the drug of this kind should not be used for long time. Yet, the headache cannot be cured radically. Besides, according to conditions with different causes, there are different sorts of drugs applied clinically, e.g. the anti-anxiety agent, anti-depressant agent, sympathetic inhibitor, calcium channel blockers and antiepileptic agents etc. Due to their severe side effects, long-term administration will make their efficacy reduced so much that the patients hâve to increase dose of drug gradually. The resuit, however, is not satisfactory. The more drugs they take, the severer the headache is. Now, Zhengtian pill (Zhengtianwan) is a Traditional Chinese medicine (TCM) whose formula comprises both TCM and chemical drug. The TCM works by a mechanism of activating blood by removing stasis and the chemical drug stopping pain. In practice, its curative effect is not definite to achieve the purpose of curing radically. Now, there are a lot of TCMs for treating headache. But most of them take effect more slowly; and this drawback will influence life quality of the patients.
Chinese Patent (No. ZL 93100050.5) disclosed a médicinal composition comprising 11 TCMs of Radix Angeiicae Sinensis (Dang gui) and Rhizoma Chuanxiong (Chuan xiong), Radix Paeoniae aiba (Bai shao), Radix Rehmanniae Preparata (Shu dihuang), Ramuius Uncariae cum Uncis (Gou teng), Cauiis Spathoiobi (Ji Xueteng), Spica Pruneiiae (Xia Kucao), Semen Cassiae (Jue mingzi), Concha Margaritifera Usta (Zhen zhumu), Rhizoma Corydaiis (Yuan hu) and Asarum herb (Xi xin). It is the fruits of long-term clinical practice under the guidance of Chinese medicine theory, having the therapeutic effects of treating headache caused by inner damage. Clinically, it can be applied to treat several headache diseases, such as the angioneurotic headache, migraine, and some symptoms like dizziness and headache etc. caused by hypertension. According to the proportion of this recipe, the granule of this composition is produced by Tasly Pharmaceutical Group Co. Ltd., named as Yang
Xue Qing Nao Granule. The functions and indications approved by the authorities are nourishing blood and calming liver, activating blood and removing obstruction in channels, used for diverse types of headache elicited by blood deficiency and hyperactivity of liver, traumatic cranial nerve syndrome, dizziness and vertigo, 5 vexation and irritation, insomnia and dreaminess. In clinic, it has been usually used for treatment headache caused by blood deficiency, blood stasis, and deficiency of Yin and hyperactivity of Yang. Since coming into the market, Yang Xue Qing Nao Granule has gained wide popularity among the patients due to its reassured therapeutic effects.
Now, it has been literarily reported that the Yang Xue Qing Nao Granule is usually prepared by the following method. The 11 TCMs are extracted with water, which is precipitated with éthanol to give the extract, and then the extract is mixed with excipients to préparé into various kinds of pharmaceutical formulations. For example, Chinese patents (No. 03140844.3, 200410019825.4) disclosed a process that the 11
TCMs were mixed in proportion, extracted with water for 3 times, combined to get an extract after appropriate concentration, which was added with 2 fold of éthanol to leave it to stand still for 24 hours to precipitate to get supernatant. The supernatant was concentrated to an extract with relative density of 1.3-1.4. The yield rate was 10%. Aforesaid extract was mixed with sucrose and dextrin in a proportion of 1:3:1 to make granule.
However, due to the different nature of each TCM, the extraction of active ingrédients by using method of extracting ail together usually results in the extraction incomplète or raises the defect of low yield rate. For example, main ingrédients of Radix Angelicae Sinensis (Dang gui) and Rhizoma Chuanxiong (Chuan xiong) are éthanol 25 soluble, so the éthanol was better. In the same manner, the Ramulus Uncariae cum
Uncis contains a variety of indole alkaloids, which is dominated by rhynchophylline and isorhynchophylline and a small amount of flavone constituents. Its water décoction and extract are proved to hâve significantly bio-active effects of sédation, analgesia and antihypertension. Thus, the extraction by water is a more suitable.
As shown in Chinese patents (200510073290.3 and 200510014828.3), 11 TCMs were disclosed, in which Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae aiba and Rhizoma Corydaiis were refluxed with éthanol to hâve a refluxing solution, the residue was mixed with the other 6 TCMs (excluding Ramulus Uncariae cum Uncis} including Radix Rehmanniae Preparata etc. and extracted with water for 3 times.
During the process of 3rd décoction, the Ramulus Uncariae cum Uncis was added, and the extraction liquid was combined to concentrate in vacuum. Ethanol was used to precipitate and the obtained solution was left standing still. After being filtered, the filtrate was mixed with aforesaid refluxing solution, and éthanol was recovered under reduced pressure, concentrated and dried to obtain the extract.
In practice, however, extracting Radix Paeoniae aiba combined with other TCMs will resuit in the final extract somewhat less in melting ability. Later addition of the Ramulus Uncariae cum Uncis into the extract may get the medicine float on the surface, so as to influence the extraction. Not only that, but the operation is * V complicated with the risk of dangerous steam. Extraction of Semen Cassiae by water is prone to cause problems of paste extracting tank or difficult draining.
In view of aforesaid problems, after repeated experimental researches, a new préparation method and a médicinal composition made by this new method hâve been developed.
DETAILED DESCRIPTION OF THE INVENTION
The objective of présent invention is to provide a pharmaceutical composition for treating headache.
Another objective of présent invention is to provide a preparing method of said composition.
Another objective of présent invention is to provide a use of said composition in préparation of drugs for treating headache, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminesso
The composition of présent invention comprises: 4-9 weight parts of Radix Angelicae Sinensis, 4-9 weight parts of Rhizoma Chuanxiong, 2-8 weight parts of Radix Paeoniae aiba, 2-8 weight parts of Radix Rehmanniae Preparata, 10-15 weight parts of Ramuius Uncariae cum Uncis, 10-15 weight parts of Cauiis Spathoiobi, 10-15 weight parts of Spica Pruneiiae, 10-15 weight parts of Semen Cassiae, 10-15 weight parts of Concha Margaritifera Usta, 4-9 weight parts of Rhizoma Corydaiis and 0.5-2 weight parts of Herba Asari. Said composition is prepared by a method as follows:
a) . Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae axe mixed, extracted by using heating refluxing with éthanol, and filtered to remove impurities; and the éthanol is recovered and concentrated to give #1 Extract for later use;
b) . Préparation of #2 Extract: Radix Paeoniae aiba is extracted by using heating refluxing with éthanol, and filtered; and the éthanol is recovered and concentrated to give #2 Extract for later use;
c) . Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum
Uncis, Cau/is Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari are mixed, decocted with water, filtered, concentrated, into which éthanol is added to leave it to stand still, and filtered; and the éthanol is recovered and concentrated to give #3 Extract for later use;
d) . Préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried and granulated to obtain the final product.
Preferably, said composition of présent invention is prepared by a method as follows:
a). Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae axe mixed, extracted by using heating refluxing with 3~6 fold of 50-80% éthanol for 2-3 fîmes, the first time for 0.5-2.5 hours; the second and/or third time for 0.5-2 hours, and filtered to remove the impurities; and the éthanol is recovered and concentrated until the relative density is 1.250-1.350 (70-80°C) to give #1 Extract for later use;
b) . Préparation of #2 Extract: Radix Paeoniae aiba is added with 3-6 fold of
50-80% éthanol, soaked, extracted by using heating refluxing for 2-3 times, the first time for 0.5-2.5 hours, the second and/or third time for 0.5-2 hours, and filtered;
and the éthanol is recovered and concentrated until the relative density is 1.10-1.35 (55—65°C) to give #2 Extract for later use;
c) . Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum 10 Uncis, Cau/is Spatholobi, Spica Prunellae, Concha Margaritifera Usta and Harba Asari are combined, decocted with 4-10 fold of water for 2-3 times, the first time for 0.5-3 hours, the second and/or third time for 1-3 hours, filtered, concentrated until the relative density is 1.06-1.10 (75~85°C), into which éthanol is added to make a final éthanol content of 60-85%, left to stand still for 12-24 hours, and filtered;
and the éthanol is recovered and concentrated until the relative density is
1.270-1.350 (75-85’C) to give #3 Extract for later use;
d) . Préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, granulated to obtain the final product.
More preferably, said composition of présent invention is prepared by a method as 20 follows:
a) . Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiaeaxe mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol is recovered and concentrated until the relative density is 1.300-1.310 (74-76’0) to give #1 Extract for later use;
b) . Préparation of #2 Extract: Radix Paeoniae aiba is added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.23-1.33 (65°C) to give #2 Extract for later use;
c) . Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spatholobi, Spica Prunellae, Concha Margaritifera Usta and Herba Asari are mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density is
1.06-1.10 (80°C), into which éthanol is added to make a final éthanol content of 65-70%, left to stand still for 12-24 hours, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.320-1.325 (79-81 ’C) to give #3 Extract for later use;
d). Préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, granulated to obtain the final product.
Wherein, said excipients in step d) include one or more kinds of filling agent and flavoring agent.
Said filling agent is selected from one or more kinds of cellulose, starch, soluble starch, sugar powder, dextrin, mannitol, sucrose, lactose and microcrystalline cellulose, etc.
Said flavoring agent is selected from one or more kinds of steviosin, aspartame, glycerol, saccharin sodium, sorbitol, mannitol, xylitol, high fructose and sodium cyclamate.
Preferably, said filling agent is selected from dextrin, starch, soluble starch, sucrose, lactose and microcrystalline cellulose, and said flavoring agent is selected from steviosin and aspartame.
Most preferably, said filling agent is selected from dextrin and flavoring agent is selected from steviosin.
In one embodiment, the ratio of aforesaid three Extracts prepared by Radix AngeUcae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae aiba, Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Semen Cassiae, Concha Margaritifera Usta, Rhizoma Corydaiis and Herba Asari to the excipients is 40:60 to 65:35 by weight percentage.
In another embodiment, the ratio of aforesaid three Extracts prepared by Radix AngeUcae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae aiba, Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Semen Cassiae, Concha Margaritifera Usta, Rhizoma Corydaiis and Herba Asari to the excipients is 55:45 to 65:35 by weight percentage.
Wherein, aforesaid ratio is a ratio of the dried extractum converted from aforesaid three Extracts to the excipients.
According to présent invention, said pharmaceutical composition can be prepared into any one of pharmaceutically acceptable oral formulations, including, but not limited to, granules, tablets and capsules, etc, preferably the granules.
According to présent invention, said formulation may be prepared by any one of pharmaceutically acceptable methods, e.g. spray drying granulation method, f luidized-bed spray granulation method, wetting granulation method, dry granulation method and rolling granulation method.
Preferably, said formulation may be prepared by the fluidized-bed spray granulation method.
According to présent invention, said fluidized—bed spray granulation method comprises following steps: taking a part of filling agent, dissolving it with purified water, adding flavoring agent to dissolve by well-stirring to give slurry; adding well-prepared three Extracts into aforesaid slurry stepwise, stirring, adjusting density of the slurry, online filtering; putting the rest of filling agent into a granulator; performing spray granulation by adjusting granulating parameters;
drying; granulating with a sieve; mixing totally and packaging to hâve the final product.
Wherein, the addition amount of said flavoring agent accounts for 0~1% by weight of the total filling agent. The ratio between the part of filling agent firstly 5 added and the rest of the filling agent is 1:4 to 1.5:1 by weight percentage.
According to présent invention, said pharmaceutical composition may be prepared into appropriate package spécification, which dépends on its various dosage forms, e.g. for the granules, the spécification can be selected from 3g/bag or 4g/bag.
îo According to présent invention, extracting method of said pharmaceutical composition is obtained by following screening experiments.
1. The reason why to extract 11 TCMs respectively
The main ingrédients of Radix Ange/icae Sinensis include: ferulic acid, capable of inhibiting blood coagulation and thrombus formation; water-soluble vitamin B12, 15 folie acid, folinic acid and nicotinic acid, capable of promoting génération of érythrocyte and hemoglobin significantly; and angelica polysaccharide, capable of facilitating growth of WBC reticular cell in mice and resisting anémia.
The main ingrédients of Rhizoma Chuanxiong include spécial smell volatile oil-like alkaloids, ferulic acid and volatile oil, etc. The alcohol extract of the Rhizoma 20 Chuanxiong has effects of dilating coronary artery, increasing coronary blood flow, protecting myocardium against ischemia, reducing blood pressure significantly, anticoagulation and anti-thrombus, etc. Besides, the tetramethylpyrazine therein is capable of sédation, dilating blood vascular, protecting myocardium against ischemia, as well as reducing blood pressure, anticoagulation and anti-thrombus, 25 etc. The main bioactive ingrédients are éthanol soluble in both Rhizoma Chuanxiong and Radix Ange/icae Sinensis, so éthanol extraction is used.
Radix Paeoniae a/ba mainly contains a number of glycosides such as paeoniflorin, as well as volatile oil, tannins and sugar. Its total glycosides are proven to hâve effects of anti-inflammation, immune régulation, protecting liver, sédation and 30 analgesia, etc. Among them, the paeoniflorin is at the highest concentration, which is easily extracted with éthanol or hot water due to its ester structure. As a resuit, the extract by éthanol solution is more stable.
The main ingrédients of Rhizoma Corydaiis are numerous alkaloids, among which the tetrahydropalmatine, corydaline, corydaiis L and dehydrocorydaline are proven 35 to hâve the stronger biological functions, capable of significantly sedating, hypnotizing, reducing coronary résistance and increasing blood flow, etc. Ail of Rhizoma Corydaiis éthanol extract, vinegar extract and water extract are found to hâve effect of relieving pain, and the éthanol one has the best effect among others. At the same time, they hâve certain of central sédation effect. Its 40 alkaloid is mainly composed of quarternary amine alkali and tertiary amine alkali;
the former is water soluble and extracted with water. Both, however, can be
extracted with éthanol solution and the yield rate is high.
Semen Cassiae contains a sériés of ingrédients of physcion, chrysophanol, emodin, rhein and Semen Cassiae lactone. Thus, extraction-by-ethanol is reasonable.
Ramu/us Uncariae cum Uncis mainly contains various types of indole alkaloids, dominated by rhynchophylline and isorhynchophylline, as well as a little flavonoid.
Both its water décoction and extract hâve marked effects of sédation, relieving pain and reducing blood pressure. Therefore, extraction-by-water is reasonable.
For the rest in this pharmaceutical composition, Radix Rehmanniae Preparata, 10 Cauiis Spathoiobi, Spica Prunellae, Concha Margaritifera Usta and Herba Asari work as adjuvant drugs and courier drugs in this formula. The chemical ingrédients contained therein include alcohols, amino acids, sterols, anthraquinones, many kinds of sugars and a variety of essential trace éléments such as Fe. The water décoction thereof is found to hâve blood-enriching effect 15 of increasing RBC count, having hemoglobin increased, reducing blood sugar, reducing blood pressure and lowering blood lipid, etc. As a resuit, according to the requirements of formula and quality of bioactive ingrédients, the waterextracting-alcohol-precipitating method is used to extract the bioactive ingrédients.
On the basis of aforesaid analysis, the extraction-by-ethanol method is applied to the medicines of Radix Ange/icae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae aiba, Rhizoma Corydaiis and Semen Cassiae', the water-extracting-alcoholprecipitating method to Radix Rehmanniae Preparata, Cauiis Spathoiobi, Spica Prunellae, Concha Margaritifera Usta and Herba Asari.
2. Investigation of extracting Radix Paeoniae aiba alone or in combination
Radix Paeoniae aiba is the main drug in the formula, whose main bioactive ingrédient, paeoniflorin, acts as a détermination indicator. The yield rate, paeoniflorin content and dissolvability were used as the indicators for investigation of extracting Radix Paeoniae aiba alone or in combination. Production processes 30 were designed respectively, wherein the 1st process included the steps of taking
Radix Paeoniae aiba at prescription dose, into which 5 fold of 70% éthanol was added to extract by refluxing twice, 2 hours for each time; and the 2nd process included the steps of taking Radix Paeoniae aiba, Radix Ange/icae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae at prescription dose, 35 into which 5 fold of 70% éthanol was added to extract by refluxing twice, 2 hours for each time. Résultant extracts were combined respectively, appropriate quantity of the extracts (approximately equal to 0.03g crude medicine of Radix Paeoniae aiba) were sucked, éthanol was added to a constant volume of 20ml, and filtered to get the liquid as the sample solution. The rest of the extracts was 40 dried to investigate their yield rate, paeoniflorin content and dissolvability.
Method for détermination of paeoniflorin
Apparatus and reagent
Agilent 1100 HPLC was equipped with quaternary pump, DAD, automatic sampler, online degasser and column thermostat.
Standard paeoniflorin (obtained from China Pharmaceutical Biological Products Analysis Institute), methanol (chromatographically pure), purified water, isopropanol, citric acid (analytically pure)
Chromatographie conditions: Agilent Zorbax SB-Cw column (250 mmx4.6mm, 5 μηη)
Mobile phase: isopropanol-methanol-5% citric acid solution (2:18:80)
Flow rate: 1.0ml/min; column température: 30°C; détection wavelength: 240nm
Préparation of testing solution: as mentioned before.
Préparation of standard solution: appropriate quantity of standard paeoniflorin was taken and weighed accurately to préparé the standard solution (with 1ml solution containing 0.015mg soluté) by adding 80% methanol.
Measuring method: 10ui testing and standard solutions were respectively sucked with accuracy, injected into the HPLC and measured.
The results were shown below.
Table 1 investigation of extracting Radix Paeoniae aiba alone or in combination
_. Paeoniflorin content
Process ,. , (mg/g)
1st process15.58
2nd process15.10
Yield rate (%) Dissolvability
2Q 63 Totally dissolved, good dissolvability
Black residues,
21.88 somewhat less dissolvability
As shown in the results, in terms of the paeoniflorin content, the extract prepared by extracting Radix Paeoniae aiba alone was slightly higher than that in combination (3.18%). In terms of the yield rate, the former was less than the latter. In terms of the dissolvability, the former was much better than the latter. Compared with the latter one, the former process had advantages of shorter concentration heating time, less paeoniflorin loss, increased transfer rate, and elevated content in product. Thus, considering various factors comprehensively, the process by extracting Radix Paeoniae aiba alone was reasonable.
3. Investigation of extracting Ramuius Uncariae cum Uncis in different ways Rhynchophylline content and yield rate were used as indicators for investigation of extracting Ramuius Uncariae cum Uncis in different ways (where Ramuius Uncariae cum Uncis is decocted earlier or later). A mixture of Radix Rehmanniae Preparata, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta, Ramuius
Uncariae cum Uncis and Herba Asari was taken at prescription dose. Production processes were designed respectively. 1st process was that aforesaid mixture was added with 6 fold of water, extracted for 3 times to hâve the extract, the first time for 2 hours, the second and third times for 1 hour. 2nd process was that Radix Rehmanniae Preparata, Cau/is Spathoiobi, Spica Prunellae and Concha Margaritifera Usta were added with 6 fold of water, extracted for 2 hours, filtered, and the résultant residues were mixed with the Ramuius Uncariae cum Uncis, extracted twice with 6 fold of water, each for 1 hour to hâve the extract. Rhynchophylline content and yield rate of afore-obtained extracts were measured respectively.
Method for détermination of rhynchophylline
Apparatus and reagent
Agilent 1100 HPLC was equipped with quaternary pump, DAD, automatic sampler, online degasser and column thermostat.
Standard rhynchophylline, methanol (chromatographically pure), purified water, triethylamine, glacial acetic acid (analytically pure)
Chromatographie conditions: Agilent Zorbax SB-Ci8 column (250 mmX4.6mm, 5 μηη)
Mobile phase: methanol-1 Ommol triethylamine solution (48:52), adjusted to pH=5.0 with acetic acid
Flow rate: 1.0ml/min; column température: 30°C; détection wavelength: 254nm
Préparation of standard solution: appropriate quantity of standard rhynchophylline was taken and weighed accurately to préparé the standard solution (with 1ml solution containing 10ug soluté) by adding methanol.
Préparation of testing solution: appropriate quantity (approximately equal to 2g crude medicine Ramuius Uncariae cum Uncis) of combined water extract was sucked, alkalified by adding 5ml ammonia water, extracted with chloroform for 3 times and combined, evaporated to dryness with water bath. The residues were dissolved by adding methanol to volume of 20ml, filtered to give the testing solution.
Measuring method: 10μΙ testing and standard solutions were respectively sucked with accuracy, injected into the HPLC and measured.
The results were shown below.
Table 2 investigation of extracting Ramuius Uncariae cum Uncis in different ways
Process | rhynchophylline content (mg) | Yield rate (%) |
1st process | 10.80 | 13.39 |
2nd process | 10.92 | 12.96 |
As shown in the results, in terms of the rhynchophylline content, the extract
prepared by 1st process was almost the same as that by 2nd process. In terms of the yield rate, the extract prepared by 1st process was slightly higher than that by 2nd process, but the différence was slight. The inconvénient operation brought by 2nd process should be considered, for example the medicine perhaps floated on 5 the surface, which may influence extraction and cause potential safety hazard.
Due to its simplified process, easy operation and enhanced safety, the 1st process was reasonable.
As shown in pharmacological research, it is confirmed that said pharmaceutical composition has effects of ameliorating cérébral pial microcirculation, increasing 10 cérébral blood flow, relaxing vasospasm and stopping pain. As shown in pharmacodynamies experiment, compared with the one prepared by methods known in prior arts, the pharmaceutical composition has an excellent effect of treating headache.
Embodiments
Example 1
The following médicinal materials were taken: 253.5g of Radix AngeUcae Sinensis, 253.5g of Rhizoma Chuanxiong, 202.7g of Radix Paeoniae aiba, 202.7g of Radix Rehmanniae Preparata, 506.8g of Ramuius Uncariae cum Uncis, 506.8g of Cauiis 20 Spathoiobi, 506.8g of Spica Pruneiiae, 506.8g of Semen Cassiae, 506.8g of
Concha Margaritifera Usta, 253.5g of Rhizoma Corydaiis and 50.5g of Herba As a ri.
Préparation of #1 Extract: Radix AngeUcae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 25 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.300-1.310 (74~76°C) to give 253g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 4 fold of 60% éthanol, 30 soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density is 1.23-1.33 (65°C) to give 42g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum 35 Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-70%, left to stand still for 12-24 hours, and filtered; and the éthanol was 40 recovered and concentrated until the relative density was 1.320-1.325 (79-81 °C) to give 305g of #3 Extract for later use.
300g of dextrin was dissolved with purified water, into which 3.0g steviosin was added to dissolve by well stirring to give slurry. 600g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~45°C), and the slurry was online filtered 5 with 60-100 mesh sifter.
250.0g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a température of 30-60°C, and dried.
The température was further increased to 80~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 2
The following médicinal materials were taken: 338g of Radix Angeh'cae Sinensis, 338g of Rhizoma Chuanxiong, 270.3g of Radix Paeoniae alba, 270.3g of Radix Rehmanniae Preparata, 675.7g of Ramuius Uncariae cum Uncis, 675.7g of Cauiis Spathoiobi, 675.7g of Spica Prunallae, 675.7g of Semen Cassiae, 675.7g of Concha Margaritifera Usta, 338g of Rhizoma Corydaiis and 67.3g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.300-1.310 (74~76°C) to give 335g of #1 25 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.23-1.33 (65°C) to give 55g of #2 Extract 30 for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 35 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-72%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.320-1.325 (79-81 °C) to give 420g of #3 Extract for later use.
83g of sucrose was dissolved with purified water by well stirring to give the slurry. 40 810g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~45°C),
and the slurry was online filtered with 60-100 mesh sifter.
320g rest of the sucrose was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fIuidized state in the fluid bed. The 5 materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
îo Example 3
The following médicinal materials were taken: 150g of Radix AngeUcae Sinensis, 150g of Rhizoma Chuanxiong, 225g of Radix Paeoniae a/ba, 225g of Radix Rehmanniae Preparata, 551g of Ramuius Uncariae cum Uncis, 551g of Cauiis Spathoiobi, 551g of Spica Pruneiiae, 551g of Semen Cassiae, 551g of Concha 15 Margaritifera U s ta, 225 g of Rhizoma Corydaiis and 19g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 5 fold of 70% éthanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and 20 concentrated until the relative density was 1.250-1.310 (70~74°C) to give 210g of #1
Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 4 fold of 80% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and 25 concentrated until the relative density was 1.15-1.25 (65°C) to give 50g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and 30 the second time for 1 hour, filtered, concentrated until the relative density was
1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 60-65%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.27-1.320 (75~80°C) to give 545g of #3 Extract for later use.
231g of dextrin was dissolved with purified water, into which 3.0g steviosin was added to dissolve by well stirring to give the slurry. 805g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered with 60-100 mesh sifter.
151g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30-60 °C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules.
The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 4
The following médicinal materials were taken: 250g of Radix Angeiicae Sinensis, 250g of Rhizoma Chuanxiong, 250g of Radix Paeoniae aiba, 250g of Radix 10 Rehmanniae Preparata, 740g of Ramuius Uncariae cum Uncis, 740g of Cauiis
Spathoiobi, 740g of Spica Pruneiiae, 740g of Semen Cassiae, 740g of Concha Margaritifera U s ta, 250g of Rhizoma Corydaiis and 50 g of Herba Asari.
Préparation of #1 Extract: Radix Ange/icae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 15 times with 4 fold of 80% éthanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.300-1.350 (75~80°C) to give 300g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 6 fold of 60% éthanol, 20 soaked, extracted by using heating refluxing for 3 times, the first time for 3 hours and the second time for 1 hour and the third time for 0.5 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.20-1.35 (60°C) to give 60g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum 25 Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 8 fold of water, the first time for 3 hours and the second time for 2 hours, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 80-85%, left to stand still for 12-24 hours, and filtered; and the éthanol was 30 recovered and concentrated until the relative density was 1.30-1.350 (80~85°C) to give 425g of #3 Extract for later use.
80g of soluble starch was dissolved with purified water, into which 3g steviosin was added to dissolve by well stirring to give the slurry. 785g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of 35 résultant slurry was adjusted to 1.12-1.23 (42-50°C), and the slurry was online filtered with 60-100 mesh sifter.
330g rest of the soluble starch was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the 40 fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules.
The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Example 5
The following médicinal materials were taken: 338g of Radix AngeUcae Sinensis, 338g of Rhizoma Chuanxiong, 75g of Radix Paeoniae aiba, 75g of Radix Rehmanniae Preparata, 510g of Ramuius Uncariae cum Uncis, 510g of Cauiis Spathoiobi, 510g of Spica Pruneiiae, 510g of Semen Cassiae, 510g of Concha Margaritifera Usta, 337g of Rhizoma Corydaiis and 37g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 50% éthanol, the first time for 2 hours and the second time for 2 hours, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.300-1.350 (73~78°C) to give 330g of #1
Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aiba was added with 5 fold of 70% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 1 hour and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.23-1.35 (65°C) to give 15g of #2 Extract 20 for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 10 fold of water, the first time for 2 hours and the second time for 2 hours, filtered, concentrated until the relative density was 25 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 63-70%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.290-1.330 (78~83°C) to give 253g of #3 Extract for later use.
320g of dextrin was dissolved with purified water, into which 3g steviosin was 30 added to dissolve by well stirring to give the slurry. 598g of well-prepared three
Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42-50’C), and the slurry was online filtered with 60-100 mesh sifter.
240g rest of the dextrin was put into the granulator. A sériés of parameters were 35 adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30-60’0, and dried. The température was further increased to 70-90’C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. 40 The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
I
Example 6
The following médicinal materials were taken: 300g of Radix Angelicae Sinensis, 300g of Rhizoma Chuanxiong, 400g of Radix Paeoniae aiba, 400g of Radix Rehmanniae Preparata, 650g of Ramuius Uncariae cum Uncis, 650g of Cauiis 5 Spathoiobi, 650g of Spica Pruneiiae, 650g of Semen Cassiae, 650g of Concha
Margaritifera U s ta, 300g of Rhizoma Corydaiis and 50g of Herba Asari.
Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 3 times with 3 fold of 60% éthanol, the first time for 2 hours, the second time for 1 hour 10 and the third time for 0.5 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.29-1.340 (73~78°C) to give 315g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawos added with 4 fold of 80% éthanol, soaked, extracted by using heating refluxing for 3 times, the first time for 2 hours, the 15 second time for 1 hour and the third time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.18-1.33 (65°C) to give 90g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari 20 were mixed, decocted for 2 times with 7 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80 °C), into which éthanol was added to make a final éthanol content of 70-75%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.310-1.330 (77~82°C) 25 to give 375g of #3 Extract for later use.
84g of dextrin was dissolved with purified water, into which 3g steviosin was added to dissolve by well stirring to give the slurry. 780g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered 30 with 60-100 mesh sifter.
336g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The 35 température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Example 7
The following médicinal materials were taken: 338g of Radix Angelicae Sinensis, 338g of Rhizoma Chuanxiong, 300g of Radix Paeoniae aiba, 300g of Radix Rehmanniae Preparata, 413g of Ramuius Uncariae cum Uncis, 413g of Cauiis Spathoiobi, 413g of Spica Pruneiiae, 413g of Semen Cassiae, 413g of Concha 5 Margaritifera U s ta, 337g of Rhizoma Corydaiis and 75g of Herba As a ri.
Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 6 fold of 70% éthanol, the first time for 2 hours and the second time for 0.5 hour, and filtered to remove the impurities; and the éthanol was recovered and 10 concentrated until the relative density was 1.260-1.310 (74~76°C) to give 300g of #1
Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aiba was added with 6 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 2 hours, and filtered; and the éthanol was recovered and 15 concentrated until the relative density was 1.21-1.34 (55°C) to give 70g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 6 fold of water, the first time for 2 hours and 20 the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-75%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.300-1.300 (79-81 °C) to give 424g of #3 Extract for later use.
40g of dextrin was dissolved with purified water, into which 3g steviosin was added to dissolve by well stirring to give the slurry. 794g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42-50’0), and the slurry was online filtered with 60-100 mesh sifter.
163g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fIuidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 8
The following médicinal materials were taken: 450g of Radix Angelicae Sinensis,
450g of Rhizoma Chuanxiong, 350g of Radix Paeoniae aiba, 350g of Radix
Rehmanniae Preparata, 570g of Ramuius Uncariae cum Uncis, 570g of Cauiis
Spathoiobi, 570g of Spica Prunellae, 570g of Semen Cassiae, 570g of Concha Margaritifera Usta, 450g of Rhizoma Corydalis and 100g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 6 fold of 80% éthanol, the first time for 1 hour and the second time for 1 hour, and fîltered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.29-1.340 (73~78°C) to give 390g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aiba was added with 3 fold of 60% éthanol, 10 soaked, extracted by using heating refluxing for 2 times, the first time for 2.5 hours and the second time for 2 hours, and fîltered; and the éthanol was recovered and concentrated until the relative density was 1.17-1.33 (65°C) to give 65g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum 15 Uncis, Cauiis Spathoiobi, Spica Prunellae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 9 fold of water, the first time for 3 hours and the second time for 3 hours, fîltered, concentrated until the relative density was 1.06-1.08 (80°C), into which éthanol was added to make a final éthanol content of 65-75%, left to stand still for 12-22 hours, and fîltered; and the éthanol was 20 recovered and concentrated until the relative density was 1.310-1.330 (77~82°C) to give 385g of #3 Extract for later use.
110g of dextrin was dissolved with purified water, into which 3g steviosin was added to dissolve by well stirring to give the slurry. 840g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant 25 slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online fîltered with 60-100 mesh sifter.
256g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The 30 materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Example 9
The following médicinal materials were taken: 253.5g of Radix Ange/icae Sinensis, 253.5g of Rhizoma Chuanxiong, 202.7g of Radix Paeoniae aiba, 202.7g of Radix Rehmanniae Preparata, 506.8g of Ramuius Uncariae cum Uncis, 506.8g of Cauiis Spathoiobi, 506.8g of Spica Prunellae, 506.8g of Semen Cassiae, 506.8g of 40 Concha Margaritifera Usta, 253.5g of Rhizoma Corydaiis and 50.5g of Herba
Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.250-1.310 (70~74°C) to give 253g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aibawas added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.23-1.33 (65°C) to give 42g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-75%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.27-1.320 (75~80°C) to give 305g of #3 Extract for later use.
300g of soluble starch was dissolved with purifîed water, into which 3.0g steviosin was added to dissolve by well stirring to give the slurry. 600g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered with 60-100 mesh sifter.
250.0g rest of the soluble starch was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 80~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 10
The following médicinal materials were taken: 338g of Radix Angeiicae Sinensis, 338g of Rhizoma Chuanxiong, 270.3g of Radix Paeoniae atba, 270.3g of Radix Rehmanniae Preparata, 675.7g of Ramuius Uncariae cum Uncis, 675.7g of Cauiis Spatho/obi, 675.7g of Spica Pruneiiae, 675.7g of Semen Cassiae, 675.7g of Concha Margaritifera Usta, 338g of Rhizoma Corydaiis and 67.3g of Herba Asari.
Préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1
hour, and filtered to remove the impurities: and the éthanol was recovered and concentrated until the relative density was 1.280-1.320 (75~80°C) to give 335g of #1 Extract for later use.
Préparation of #2 Extract: RadixPaeoniae aiba was added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.23-1.33 (65°C) to give 55g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 60-65%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.315-1.320 (76~79°C) to give 420g of #3 Extract for later use.
80g of microcrystalline cellulose was dissolved with purified water, into which 3.0g aspartame was added to dissolve by well stirring to give the slurry. 810g of wellprepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered with 60-100 mesh sifter.
320g rest of the microcrystalline cellulose was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Example 11
The following médicinal materials were taken: 150g of Radix Angelicae Sinensis, 150g of Rhizoma Chuanxiong, 225g of Radix Paeoniae aiba, 225g of Radix Rehmanniae Preparata, 551g of Ramulus Uncariae cum Uncis, 551g of Cauiis Spathoiobi, 551g of Spica Pruneiiae, 551g of Semen Cassiae, 551g of Concha Margaritifera Usta, 225g of Rhizoma Corydalis and 19g of Herba Asari.
Préparation of #1 Extract: Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 5 fold of 70% éthanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.290-1.300 (75~77°C) to give 210g of #1 Extract for later use.
Préparation of #2 Extract: RadixPaeoniae aibawas added with 4 fold of 80% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 2 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.15-1.25 (65°C) to give 50g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 65-70%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.310-1.315 (79~82°C) to give 545g of #3 Extract for later use.
231g of lactose was dissolved with purified water, into which 3.0g aspartame was added to dissolve by well stirring to give the slurry. 805g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42~50°C), and the slurry was online filtered with 60-100 mesh sifter.
151g rest of the lactose was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with spécification of 4g/bag.
Example 12
The following médicinal materials were taken: 250g of Radix AngeUcae Sinensis, 250g of Rhizoma Chuanxiong, 250g of Radix Paeoniae aiba, 250g of Radix Rehmanniae Preparata, 740g of Ramuius Uncariae cum Uncis, 740g of Cauiis Spathoiobi, 740g of Spica Pruneiiae, 740g of Semen Cassiae, 740g of Concha Margaritifera Usta, 250g of Rhizoma Corydaiis and 50g of Herba Asari.
Préparation of #1 Extract: Radix AngeUcae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae were mixed, extracted by using heating refluxing for 2 times with 4 fold of 80% éthanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol was recovered and concentrated until the relative density was 1.280-1.300 (75~77°C) to give 300g of #1 Extract for later use.
Préparation of #2 Extract: Radix Paeoniae aiba was added with 6 fold of 60% éthanol, soaked, extracted by using heating refluxing for 3 times, the first time for 2 hours, the second time for 1 hour and the third time for 0.5 hour, and filtered; and the éthanol
was recovered and concentrated until the relative density was 1.20-1.35 (60°C) to give 60g of #2 Extract for later use.
Préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari 5 were mixed, decocted for 2 times with 8 fold of water, the first time for 3 hours and the second time for 2 hour, filtered, concentrated until the relative density was 1.06-1.10 (80°C), into which éthanol was added to make a final éthanol content of 80-85%, left to stand still for 12-24 hours, and filtered; and the éthanol was recovered and concentrated until the relative density was 1.280-1.330 (75-80°C) 10 to give 425g of #3 Extract for later use.
80g of dextrin was dissolved with purified water, into which 3g aspartame was added to dissolve by well stirring to give the slurry. 785g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of résultant slurry was adjusted to 1.12-1.23 (42-50°C), and the slurry was online filtered 15 with 60-100 mesh sifter.
330g rest of the dextrin was put into the granulator. A sériés of parameters were adjusted, e.g. fan frequency, température of inlet air, frequency of liquid feed and spray pressure, to make materials in well—fluidized state in the fluid bed. The materials were spray-granulated at a température of 30~60°C, and dried. The 20 température was further increased to 70~90°C to thoroughly dry.
The résultant granules were sorted, sifted and totally mixed to produce granules.
The package was aluminum-plastic composite film pillow bag with spécification of 3g/bag.
Bénéficiai effects of said pharmaceutical compositions on treating headache hâve 25 been demonstrated by following 2 pharmacodynamie researches.
Pharmacodynamie Research 1. Ameliorating effect of pharmaceutical composition (YXQN) on nitroglycerin-induced migraine in rats
1. Materials
1.1 Animais: SD rats, male, weighing 180-200g were provided by Beijing 30 Weitongiihua Experimental Animal Technology Co., Ltd. The animais were raised in separate cages under natural light with excellent ventilation and free access to water and food. Animal diet was pellet feed purchased from Jinan Dakang Feed Inc. (Certificate No.: 364). Feeding environment for test animais was in accordance with the Régulation of Test Animais Tianjin.
1.2 Drug: tested drug was prepared by the method of Example 1 (YXQN-1), and comparison drug by the method of Chinese patent ZL20051 0073290.3 (YXQN-2). Both were provided by Tasly Pharmaceutical Co., Ltd. Qiyeanshen tabiet (Approval. No.: Z45022054), as a positive control drug, was produced by Guangxi Beihai Pharmaceutical Co., Ltd (LOT: 20130123). Daily dosage: 20mg per day.
1.3 Reagent: NOS assay kit, Coomassie brilliant blue protein assay kit and NO assay kit were purchased from Nanjing Jiancheng Science & technology Co., Ltd
(LOT:20120726), Rat 5-HT kit was purchased from Shanghai Jianglai Bio-tech Co., Ltd (LOT:12-05), ELISA kit was purchased from Shanghai Meilian Bio-tech Co., Ltd and rat DA ELISA kit was purchased from Shanghai Kaibo Bio-tech Co., Ltd. Normal saline and 10% chloral hydrate.
1.4 Apparatus: Shimadzu UV2100 ultraviolet spectrophotometer, FLUKO F6/10 high-shearing dispersion emulsifier, Hettich ROTANTA 460R high-speed refrigerated centrifuge, Electronic balance and ultrasound Doppler blood stream detector.
2. Method
2.1 Grouping and administration
Animais were randomly divided into 9 groups according to body weight, 10 rats in each group: the model group; positive control group; blank control group; high, middle and low dosage groups of YXQN-1 (1.562g, 0.781g and 0.391 extract/kg respectively); high, middle and low dosage groups of YXQN-2 (1.562g, 0.781g 15 and 0.391 extract/kg respectively). Preventively, YXQN-1, YXQN-2 and positive control groups were administrated for 10 consecutive days. Positive drug was given at a dosage of 20mg per day. Equal volume of normal saline was intragastrically administrated to model group and blank control group.
2.2 Establishment of behavior observation model
Except the blank control group, remaining rats received subcutaneous injection of nitroglycerin (10ml/kg). Experimental migrainous rat models were duplicated.
After administrated intragastrically, those rats, having two reddish ears and increased frequency of scratching head with forepaws, were taken as successful modeling. (1) Reddish ear: to observe the time the reddish ear appeared and 25 disappeared after modeling; (2) Scratching head: to observe the frequency of scratching head every 30min after modeling, the time scratching head appeared with consecutive scratching head for 5 times or more as the symbol, and the time scratching head disappeared with scratching head of less than 5 times during an interval, dépréssion and fatigue as the symbol.
2.3 détermination of bio-marker
Ail animal models were made and administrated in light of aforesaid method. Blood and brain were collected 4 hours after modeling to préparé blood and brain homogenates, and frozen reserved for later use. Method of chemical colorimetry was performed in accordance with the label of the kit to assay NO content and 35 NOS activity in sérum; as well as 5-HT, 5-HIAA, NA DA contents in brain.
2.4 Statistical management
Ail data were analyzed with SPSS 20.0 software, results were expressed as X±s and t-test was used between groups.
3. Results
3.1 Reddish ears
No reddish ear was observed in blank control group. Reddish ears appeared in YXQN-1, YXQN-2 and model group 3 min after modeling. Compared with the
model group, there was no significant différence in the time reddish ears appeared. After treatment, compared with the model group, the time reddish ears disappeared in middle and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01), however, no significant différence was found in 5 the YXQN-2 groups. Compared with the equal dosage group of YXQN-2, the high and middle dosage groups of YXQN-1 had significant différence (P<0.05). The results were shown in Table 3.
Table 3 effect of YXQN-1 and YXQN-2 on the time reddish ears appeared and disappeared in rats (min, ^±s)
Groups | n | Reddish ear appeared (min) | Reddish ear disappeared (min) |
Blank control group | 10 | 0 | 0 |
Model group | 10 | 3.28±0.21 | 187.26±10.44 |
Qiyeanshen Tablet | 10 | 3.66±0.50 | 109.45±14.22 * |
YXQN-1 (High) | 10 | 3.55±0.72 | 99.26±15.28 # |
YXQN-1 (Middle) | 10 | 3.44±0.52 | 111,87±9.92 ** # |
YXQN-1 (Low) | 10 | 3.15±0.33 | 126.95±9.10 * |
YXQN-2 (High) | 10 | 3.29±0.60 | 125.49±13.19 |
YXQN-2 (middle) | 10 | 3.83±0.86 | 1 35.99±1 0.11 |
YXQN-2 (Low) | 10 | 3.55±0.19 | 138.95±12.22 |
Compared with the model group, * P<0.05, ** P<0.01; compared with
YXQN-2, # P<0.05.
3.2 Frequency of scratching head
In the blank control group, scratching head occasionally appeared once or twice during a few period of time. At about 3rd min after modeling, scratching head 15 appeared in YXQN-1, YXQN-2 and model groups, having no statistical significance, as compared with the model group. After treatment, there were more times of scratching head during period of 0th~30th min and 30,h~60th min. Compared with the model group, the high, middle and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01) in frequency of scratching 20 head. The significant différence had not yet been found in each dosage group of the YXQN-2. Compared with the equal dosage group of YXQN-2, the middle and low dosage groups of YXQN-1 had significant différence (P<0.05). The results were shown in Table 4.
Table 4 effect of YXQN-1 and YXQN-2 on the frequency of scratching head in rats (Y±s) during each period of time
Group | N | Frequency | Frequency |
(0~30min) | (30~60min) | ||
Blank control group | 10 | 0 | 0 |
Model group | 10 | 1 7.9±1.1 | 86.4±17.1 |
Qiyeanshen Tablet | 10 | 6.1 ±2.0 ** | 30.4±2.7 * |
YXQN-1 (High) | 10 | 1 0.4±2.9 ** | 26.9 + 5.1 | ★ ★ |
YXQN-1 (Middle) | 10 | 12.1 ±1.5 * # | 37.3+3.7 | * # |
YXQN-1 (Low) | 10 | 1 3.3 + 1.6 * # | 49.6+3.6 | * # |
YXQN-2 (High) | 10 | 12.5 + 2.4 | 45.9+4.1 | |
YXQN-2 (middle) | 10 | 15.3+2.5 | 50.2 + 5.6 | |
YXQN-2 (Low) | 10 | 16.3 + 2.8 | 55.5 + 2.9 |
Compared with the model group, * P<0.05, ** P<0.01; compared with YXQN-2, # P<0.05.
3.3 Level of NO and NOS in sérum
Compared with the model group, the sérum level of NO and NOS in rats in the high, middle and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01). The significant différence had not yet been found in each dosage group of the YXQN-2. Compared with the equal dosage group of YXQN-2, the middle and low dosage groups of YXQN-1 had significant différence (P<0.05). The results were shown in Table 5.
Tablet 5 effect of YXQN-1 and YXQN-2 on the sérum level of NO and NOS in rats (x±s)
Group | N | NO (pmol/L) | NOS (U/ml) |
Blank control group | 10 | 30.64+11.18 | 20.84 + 1.89 |
Model group | 10 | 130.21+11.39 | 47.84 + 1.91 |
Qiyeanshen Tablet | 10 | 78.13 + 18.16 ** 28.78 + 3.75* | |
YXQN-1 (High) | 10 | 83.76 + 17.94** | 45.19 + 4.28 ** |
YXQN-1 (Middle) | 10 | 96.10 + 11.73 * | # 47.3 + 2.28 * # |
YXQN-1 (Low) | 10 | 107.72 + 15.9 * | „ 49.31 ±1.53 · * # |
YXQN-2 (High) | 10 | 97.33 + 16.23 | 48.22 + 4.28 |
YXQN-2 (middle) | 10 | 101.11+19.01 | 50.2 + 5.6 |
YXQN-2 (Low) | 10 | 118.72 + 18.75 | 55.5 + 2.9 |
Compared with the | model | group, * P<0.05, ** | P<O.O1; compared |
YXQN-2, # P<0.05.
3.4 Contents of 5-HT, 5-HIAA and DA
Compared with the model group, the contents of 5-HT, 5-HIAA and DA in rats in the high, middle and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01). The significant différence had not yet been found in each dosage group of the YXQN-2. In terms of 5-HT and 5-HIAA, compared with the equal dosage group of YXQN-2, the middle and low dosage groups of YXQN-1 had significant différence (P<0.05). In terms of DA, compared with the equal dosage group of YXQN-2, the middle and high dosage groups of YXQN-1 had significant différence (P<0.05). The results were shown in Table 6.
Table 6 effect of YXQN-1 and YXQN-2 on the contents of 5-HT, 5-HIAA and DA in
rats (-x±s)
Group | n | 5-HT (ng/g) | 5-HIAA (mg/d) | DA (ng/L) | |
Blank control group | 10 | 201,7±7.8 | 125.23±11.22 | 49.33±10.51 | |
Model group | 10 | 126.6±7.8 | 247.48±1.10 | 65.16±12.90 | |
Qiyeanshen Tablet | 10 | 185.3±6.1* | 129.65±3.10* | 54.04±11.27 | |
YXQN-1 (High) | 10 | 185.2±2.8* | 130.19±24.28 ** | 56.01 ±11.51 *# | |
YXQN-1 (Middle) | 10 | 171,9±3.3 * | # | 139.3±22.28 * # | 59.11 ±1 0.85*# |
YXQN-1 (Low) | 10 | 158.3±4.6 * | # | 149.31 ±1.53 * # | 61,08±10.51 * |
YXQN-2 (High) | 10 | 170.3±6.3 | 158.22±34.20 | 59.67±10.32 | |
YXQN-2 (middle) | 10 | 145.1 ±9.1 | 168.20±25.60 | 61,28±14.32 | |
YXQN-2 (Low) | 10 | 120.72±8.5 | 155.5±23.90 | 61,54±15.20 |
4. Conclusion
Said pharmaceutical composition of présent invention may ameliorate nitroglycerin-induced behavioral indices and biochemical indices in models of migraine rats. As shown in the research, said pharmaceutical composition of présent invention is proven to hâve an effect on ameliorating nitroglycerin-induced behavioral indices in models of migraine rats, which is better than the comparison drug.
Pharmacodynamie Research 2. Effect of pharmaceutical composition (YXQN) on change of cérébral blood flow in model of migraine rabbits
1. Materials
1.1 Commercially available 36 rabbits, weighing 2.2 ± 0.5kg, were randomly divided into 6 groups, 6 rabbits in each group. The animais were raised in laboratory of basic medicine college of Tianjin Medical University, under natural light with excellent ventilation and free access to water and food.
1.2 Drugs: tested drug was prepared by the method of Example 1 (YXQN-1), and comparison drug was prepared by the method of Chinese patent ZL200510073290.3 (YXQN-2). Both were provided by Tasly Pharmaceutical Co., Ltd.
1.3 Apparatus: ultrasound Doppler blood stream detector
2. Method
2.1 Grouping and administration
Animais were randomly divided into 6 groups according to body weight, 6 rabbits in each group: the model group; blank control group; high, and low dosage groups of YXQN-1 (0.782g and 0.391g extract/kg respectively); high and low dosage groups of YXQN-2 (0.782g and 0.391g extract/kg respectively). The model and blank control groups were administrated by gastric perfusion with equal volume of normal saline. Animal modeling method was the same as aforesaid Pharmacodynamie Research 1. Except treatment by drugs, the model group was administrated by ear vein injection of 5-HT (2mg/kg) for consecutive 3 days, and at 3rd day Diazepam injection (7.5mg/rabbit) was added. Cérébral blood flow was
assayed 30min after the last administration. The rabbits were fixed in rabbit hutch. 2MHz detector was used on the temporal to detect, with a sampling volume of 7mm and a depth of 26±2mm.
2. Statistical management
Ail results were expressed as £±s and t—test was used between groups.
Pl=2x (Vs-Vd) /(Vs+Vd)
PI: puise index
Vs: blood flow velocity of contraction peak
Vd: blood flow velocity of diastole end
Vm: mean blood flow velocity
3. Results
3.1 Vs, Vd, Vm and PI
Blood flow velocity in the blank control group remained unchanged. After modeling, the blood flow velocities in YXQN-1, YXQN-2 and model groups were 15 decreased, having no statistical significance, as compared with the model group.
After treatment, compared with the model group, the high and low dosage groups of YXQN-1 had statistical significance (P<0.05, P<0.01). The significant différence had not yet been found in each dosage group of the YXQN-2. Compared with the equal dosage group of YXQN-2, the high dosage group of 20 YXQN-1 had significant différence (P<0.05). The results were shown in Table 7.
Tablet 7 effect of YXQN-1 and YXQN-2 on the change of cérébral blood flow in rabbits (^±s)
Group | n | Vs (cm/s) | Vd (cm/s) | Vm (cm/s) | PI |
Blank control group | 6 | 43.53±4.8 | 40.33±3.22 | 41,56±3.51 | 0.082±0.001 |
Model group | 6 | 24.71 ±4.54 | 19.48±3.10 | 21,16±2.90 | 0.23±0.03 |
YXQN-1 (high) | 6 | 39.23±5.84* | 34.34±4.98 ** | 35.01 ±4.23 | 0.22±0.03 |
YXQN-1 (low) | 6 | 38.33±4.63* # | 33.76±4.96 * # | 34.08±3.51 | 0.21 ±0.03 |
YXQN-2(high) | 6 | 30.22±4.31 | 28.13±4.20 | 30.55±5.32 | 0.23±0.03 |
YXQN-2(low) | 6 | 29.18±5.5 | 27.99±4.90 | 27.34±4.20 | 0.21+0.03 |
4. Conclusion
Said pharmaceutical composition of présent invention may ameliorate change of 25 cérébral blood flow in model of migraine rabbits. As shown in this research, said pharmaceutical composition could improve the nitroglycerin-induced change of cérébral blood flow in migraine rabbits, which was better than the comparison drug.
Claims (10)
- What is claimed is:1. A pharmaceutical composition for treatment parts of Radix Angeiicae Sinensis, 4-9 weight weight parts of Radix Paeoniae aiba, 2-8 weight parts of Radix Rehmanniae Preparata, 10-15 weight parts of Ramuius Uncariae cum Uncis, 10-15 weight parts of Cauiis Spathoiobi, 10-15 weight parts of Spica Pruneiiae, 10-15 weight parts of Semen Cassiae, 10-15 weight parts of Concha Margaritifera Usta, 4-9 weight parts of Rhizoma Corydaiis and 0.5-2 weight parts of Harba Asari, characterized in that said composition is prepared by a method as follows:a), préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae axe mixed, extracted by using heating refluxing with éthanol, and filtered to remove impurities; and the éthanol is recovered and concentrated to give #1 Extract for later use;b), préparation of #2 Extract: Radix Paeoniae aiba is extracted by using heating refluxing with éthanol, and filtered: and the éthanol is recovered and concentrated to give #2 Extract for later use;c) . préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari are mixed, decocted with water, filtered, concentrated, into which éthanol is added to leave it to stand still, and filtered; and the éthanol is recovered and concentrated to give #3 Extract for later use;d) . préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, and granulated to obtain the final product.
- 2. The composition according to claim 1, characterized in that said composition is prepared by a method as follows:a) , préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae axe mixed, extracted by using heating refluxing with 3~6 fold of 50-80% éthanol for 2-3 times, the first time for 0.5-2.5 hours, the second and/or third time for 0.5-2 hours, and filtered to remove the impurities; and the éthanol is recovered and concentrated until the relative density is 1.250-1.350 at 70-80°C to give #1 Extract for later use;b) , préparation of #2 Extract: Radix Paeoniae aiba is added with 3-6 fold of 50-80% éthanol, soaked, extracted by using heating refluxing for 2-3 times, the first time for 0.5-2.5 hours, the second and/or third time for 0.5-2 hours, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.10-1.35 at 55-65°C to give #2 Extract for later use;c) . préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari are combined, decocted with 4-10 fold of water for 2-3 times, the first time for 0.5-3 hours, the second and/or third time for 1-3 hours, filtered, concentrated until the relative density is 1.06-1.10 at 75~85°C, into which éthanol is added to make a final éthanol content of 60-85%, left to stand still for 12-24 hours, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.270-1.350 at 75~85°C to give #3 Extract for later use;d). préparation of formulations: aforesaid three Extracts are added with5 appropriate amount of excipients, dried, granulated to obtain the final product.
- 3. The composition according to claim 2, characterized in that said composition is prepared by a method as follows:a), préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, 10 Rhizoma Corydaiis and Semen Cassiae are mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% éthanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the éthanol is recovered and concentrated until the relative density is 1.300-1.310 at 74~76°C to give #1 Extract for later use;15 b), préparation of #2 Extract: Radix Paeoniae aiba is added with 4 fold of 60% éthanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.23-1.33 at 65°C to give #2 Extract for later use;20 c). préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cumUncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari are mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density is1.06-1.10 at 80°C, into which éthanol is added to make a final éthanol content of 25 65-70%, left to stand still for 12-24 hours, and filtered; and the éthanol is recovered and concentrated until the relative density is 1.320-1.325 at 79-81 °C to give #3 Extract for later use;d). préparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, granulated to obtain the final product.
- 4. The composition according to any one of claims 1-3, characterized in that said excipients in step d) include one or more kinds of filling agent and flavoring agent; preferably, said filling agent is selected from dextrin, starch, soluble starch, sucrose, lactose and microcrystalline cellulose; said flavoring agent is selected35 from steviosin, aspartame; most preferably, said filling agent is dextrin and said flavoring agent is steviosin.
- 5. The composition according to claim 1, characterized in that the weight ratio of aforesaid three Extracts prepared by Radix AngeUcae Sinensis, Rhizoma Chuanxiong,40 Radix Paeoniae aiba, Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis,Cauiis Spathoiobi, Spica Pruneiiae, Semen Cassiae, Concha Margaritifera Usta, Rhizoma Corydaiis and Herba Asari to the excipients is 40:60 to 65:35, preferably 55:45 to 65:35.
- 6. The composition according to claim 5, characterized in that said ratio of aforesaid three Extracts to the excipients is a ratio of dried extractum converted from aforesaid three Extracts to the excipients.5
- 7. The composition according to claim 1, characterized in that, in step d), the formulation is prepared by fluidized-bed spray granulation method, comprising following steps: taking a part of filling agent, dissolving it with purified water, adding flavoring agent to dissolve by well—stirring to give slurry; adding wellprepared three Extracts into aforesaid slurry stepwise, stirring, adjusting density of 10 the slurry, online filtering; putting the rest of filling agent into a granulator; performing spray granulation by adjusting granulating parameters; drying; granulating with a sieve; mixing totally and packaging to obtain the final product.
- 8. The composition according to claim 7, characterized in that addition amount of15 said flavoring agent accounts for 0-1% by weight of the total filling agent, and the weight ratio between the part of filling agent firstly added and the rest of the filling agent added later is 1:4 to 1.5:1.
- 9. A method for preparing the pharmaceutical composition of any one of claims20 1 -8, characterized in that the method comprising following steps:a), préparation of #1 Extract: Radix Angeiicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydaiis and Semen Cassiae are mixed, extracted by using heating refluxing with éthanol, and filtered to remove impurities; and the éthanol is recovered and concentrated to give #1 Extract for later use;25 b), préparation of #2 Extract: Radix Paeoniae aiba is extracted by using heating refluxing with éthanol, and filtered; and the éthanol is recovered and concentrated to give #2 Extract for later use;c) . préparation of #3 Extract: Radix Rehmanniae Preparata, Ramuius Uncariae cum Uncis, Cauiis Spathoiobi, Spica Pruneiiae, Concha Margaritifera Usta and Herba Asari30 are mixed, decocted with water, filtered, concentrated, into which éthanol is added to leave it to stand still, and filtered; and the éthanol is recovered and concentrated to give #3 Extract for later use;d) . préparation of formulations: taking a part of filling agent, dissolving it with purified water, adding flavoring agent to dissolve by well—stirring to give slurry;35 adding well-prepared three Extracts into aforesaid slurry stepwise, stirring, adjusting density of the slurry, online filtering; putting the rest of filling agent into a granulator; performing spray granulation by adjusting granulating parameters; drying; granulating with a sieve; mixing totally and packaging to obtain the final product.
- 10. Use of the pharmaceutical composition of any one of claims 1-8 in préparation of medicine for treating headache, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210562103.8 | 2012-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA17543A true OA17543A (en) | 2017-02-13 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2013362431B2 (en) | Pharmaceutical composition for treating headache, and preparation method thereof | |
CN102416139B (en) | Chinese medicine composition for treating breast diseases | |
CN100584373C (en) | Preparation process of medicine for treating cerebral apoplexy and its sequela | |
KR101088539B1 (en) | Chinese medicinal compositions for treating headache, formulations and processes for preparation therof | |
CN113018405B (en) | Traditional Chinese medicine composition for treating post-stroke depression and preparation method thereof | |
AU2015345884B2 (en) | Drug or health care product preventing or treating liver and kidney damage-related diseases and use thereof | |
CN104225006A (en) | Traditional Chinese medicine composition capable of invigorating Qi and relaxing bowels | |
CN104027428B (en) | Preparation method of traditional Chinese medicine compound and application of traditional Chinese medicine compound in prevention and treatment of senile dementia | |
CN109224038B (en) | Traditional Chinese medicine composition containing channel-inducing medicine evodia rutaecarpa for treating blood stasis collateral blocking type hepatic fibrosis and preparation method and application thereof | |
CN100371012C (en) | Medicinal composition, and its preparing method and use | |
CN101716269B (en) | Traditional Chinese medicine composition for treating hyperpiesia | |
CN102895387B (en) | Kidney-yang-warming medicine composition, and preparation thereof and preparation method thereof | |
CN102670711B (en) | White flower salviae miltiorrhizae extract for curing angiitis, preparation method and application | |
OA17543A (en) | Pharmaceutical composition for treating headache, and preparation method thereof. | |
CN102813873A (en) | Traditional Chinese medicine composition for treating mental diseases, and preparation method, application and quality control thereof | |
CN1695728A (en) | Oral taking preparation of Chinese traditional medicine for nourishing the kidney and the lung | |
CN1321632C (en) | Compound saussurea involucrata capsule and its preparation process | |
CN106466396B (en) | Gynaecologic menstruation regulating sustained-release dropping pill and preparation method thereof | |
CN105617251B (en) | Traditional Chinese medicine composition for treating depression and preparation method thereof | |
CN105106153B (en) | A kind of papaya tablet | |
CN102973624A (en) | Compound ginkgo leaf preparation and preparation method thereof | |
CN115814041A (en) | A Chinese medicinal composition for treating headache, and its preparation method | |
CN101239138A (en) | 'Zishuiqinggan'oral preparation and preparation thereof | |
CN105617165A (en) | Application of Chinese herbal composition to preparation of medicine for treating vagina hemorrhage |